FIELD: chemistry.
SUBSTANCE: invention concerns crystal habits of fluvastatin sodium salt hydrates referred to as polymorphic crystal habits C, D, E and F. Production method of these crystal habits, pharmaceutical composition for 3-hydroxy-3-methylglutaryl- coenzyme YMG-CoA inhibition based on these crystal habits C, D, E, F are described.
EFFECT: production of crystal habits of fluvastatin sodium salt hydrates.
8 cl, 6 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POROUS CRYSTALLINE MATERIAL (ZEOLITE ITQ-21),THE METHOD OF ITS PRODUCTION AND ITS APPLICATION IN THE PROCESSES OF THE CATALYTIC CONVERSION OF THE ORGANIC COMPOUNDS | 2002 |
|
RU2296104C2 |
| FORM VI OF ATORVASTATIN CALCIUM AND ITS HYDRATES | 2002 |
|
RU2294924C2 |
| CRYSTALLINE FORMS OF MONOSODIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN | 2008 |
|
RU2476440C2 |
| NOVEL CRYSTALLINE FORMS OF PYRROLYL HEPTANOIC ACID DERIVATIVES | 2008 |
|
RU2421445C1 |
| PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2121835C1 |
| NOVEL POLYMORPHOUS FORM OF CRYSTALLINE HEMICALCIUM SALT OF ATORVASTATIN | 2006 |
|
RU2409563C2 |
| ALISKIREN AND OROTIC ACID SALT | 2007 |
|
RU2456267C2 |
| CRYSTAL COMPOUNDS | 2016 |
|
RU2789672C2 |
| METHOD FOR XYLENE AND ETHYLBENZENE ISOMERISATION USING UZM-35 | 2010 |
|
RU2514423C1 |
| CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE, SUITABLE FOR TREATMENT OF ABNORMAL GROWTH OF CELLS IN MAMMALS | 2008 |
|
RU2518898C2 |
